category,datetime,headline,id,image,related,source,summary,url
company,1768236003,COO or WST: Which Is the Better Value Stock Right Now?,138078232,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WST,Yahoo,COO vs. WST: Which Stock Is the Better Value Option?,https://finnhub.io/api/news?id=b05963fe669039c1e22e68b85f993a6a65f6ce8f11dfb3ec9145d15bee960fe9
company,1768215600,"AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States",138071380,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WST,Yahoo,"AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West. The acquisition of the manufacturing site will significantly expand AbbVie's drug delivery device manufacturing capabilities and capacity.",https://finnhub.io/api/news?id=ac8939b079978297f76c5203c80b3d85f43c27989f0f3359a46d90ef9f10ea61
company,1768215600,West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie,138071379,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WST,Yahoo,"West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company has reached a definitive agreement to sell all manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for total consideration of $112.5 million at close, subject to working capital and other adjustments. The definitive agreement, which is subject to certain closing condit",https://finnhub.io/api/news?id=eee722e6bd9a5d798dc451e61f082eb755157a413dff8ba85c2570e2848aa6a2
